Goeschen K, Fuchs A R, Fuchs F, Saling E
Geburtshilfe Frauenheilkd. 1984 Jan;44(1):14-8. doi: 10.1055/s-2008-1036418.
In this investigation, the Oxytocin (OT) and 13, 14-Dihydro-15 Keto PGF 2-alpha (PGFM) levels were investigated in patients who required ripening of the cervix prior to induction of labour. Under randomized conditions four PGE2-Gel-groups and 1 Placebo group was formed. The patients who received PGE2-Gel were treated either with .4 mg PGE2-Gel intercervically without prior treatment with Betamimetica (n = 6) or 30 minutes prior to the application of .4 mg PGE2-Gel intercervically with 5 mb Fenoterol (n = 6) or 10 mg Ritadrine (n = 6) or 20 micrograms Clenbuterol (n = 6). These drugs were given by mouth. A control group of 6 patients received Gel without PGE2 Placebo. In previous investigations, it was shown that the Oxytocin level rises following the intercervical administration of PGE2-Gel to an unripe cervix whereas the PGFM level remains unchanged. Oral administration of Fenoterol inhibited the PG induced rise of the Oxytocin level and kept the Oxytocin level in the same range as following the administration of a Placebo. The present investigation served to check whether Ritadrine and Clenbuterol had an Oxytocin inhibiting effect as well as Fenoterol. It was found that administration of Betamimetica did not inhibit the ripening effect of PGE2-Gel on the cervix. Although labour did not start in 12 of 18 women treated with Betamimetica during four hours, the cervix ripened in the same manner as in women with labour. The administration of Placebo instead of PGE2-Gel showed no ripening effect (P less than 00001). Following the administration of Fenoterol the maternal heart rate increases significantly compared to Placebo.(ABSTRACT TRUNCATED AT 250 WORDS)
在本研究中,对需要在引产之前使宫颈成熟的患者的催产素(OT)和13,14 - 二氢 - 15 - 酮 - PGF2α(PGFM)水平进行了研究。在随机条件下,形成了四个PGE2凝胶组和一个安慰剂组。接受PGE2凝胶治疗的患者,要么在未预先用β - 拟交感神经药治疗的情况下,宫颈内给予0.4mg PGE2凝胶(n = 6),要么在宫颈内给予0.4mg PGE2凝胶前30分钟口服5mg非诺特罗(n = 6)、10mg利托君(n = 6)或20μg克仑特罗(n = 6)。这些药物通过口服给药。一个由6名患者组成的对照组接受不含PGE2的凝胶安慰剂。在先前的研究中表明,向未成熟宫颈宫颈内给予PGE2凝胶后催产素水平会升高,而PGFM水平保持不变。口服非诺特罗可抑制PG诱导的催产素水平升高,并使催产素水平保持在与给予安慰剂后相同的范围内。本研究旨在检验利托君和克仑特罗是否也具有与非诺特罗一样的催产素抑制作用。结果发现,给予β - 拟交感神经药并不抑制PGE2凝胶对宫颈的成熟作用。尽管在接受β - 拟交感神经药治疗的18名女性中有12名在4小时内未开始分娩,但宫颈成熟的方式与分娩女性相同。给予安慰剂而非PGE2凝胶未显示出成熟作用(P小于0.00001)。与安慰剂相比,给予非诺特罗后母体心率显著增加。(摘要截断于250字)